Literature DB >> 29367368

Lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) during primary Epstein-Barr virus (EBV) infection.

Ibrahim Tawhari1, Fawaz Tawhari2, Mossab Aljuaid1.   

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, potentially life-threatening idiosyncratic drug reaction that may result in skin eruption, mucous membrane involvement, eosinophilia, atypical lymphocytosis and lymphadenopathy, with wide-ranging internal organ involvement. The authors report the case of a 21-year-old man who was prescribed lamotrigine for anxiety disorder. After 2 weeks of treatment, he developed a pruritic morbilliform rash on his trunk and upper extremities that was associated with fever, sore throat, bilateral scleral injection, nausea, vomiting and abdominal pain. A laboratory work-up revealed elevated transaminases and atypical lymphocytosis. He was found to have an active Epstein-Barr virus infection. Lamotrigine was discontinued due to suspicion of DRESS; the patient received pulsed intravenous methylprednisolone followed by oral prednisone taper, which resulted in a significant improvement of symptoms. At follow-up 3 weeks later, signs and symptoms had completely resolved. Follow-up laboratory tests revealed that liver dysfunction had normalised. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  dermatology; drugs and medicines; infections

Mesh:

Substances:

Year:  2018        PMID: 29367368      PMCID: PMC5786957          DOI: 10.1136/bcr-2017-222416

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient.

Authors:  Emmanuel Mahé; Christine Bodemer; Laurent Dupic; Philippe Hubert; Florence Lacaille; Olivier Goulet; Marianne Leruez-Ville; Sylvie Fraitag
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

2.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

3.  Drug-induced hypersensivity syndrome associated with Epstein-Barr virus infection: a pediatric case report.

Authors:  Paola Scagni; Maura Morello; Marisa Vietti Ramus; Manuela Agostini; Rosaura Pagliero
Journal:  Pediatr Dermatol       Date:  2009 Mar-Apr       Impact factor: 1.588

4.  Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.

Authors:  Damien Picard; Baptiste Janela; Vincent Descamps; Michel D'Incan; Philippe Courville; Serge Jacquot; Sylvie Rogez; Laurent Mardivirin; Hélène Moins-Teisserenc; Antoine Toubert; Jacques Benichou; Pascal Joly; Philippe Musette
Journal:  Sci Transl Med       Date:  2010-08-25       Impact factor: 17.956

Review 5.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

6.  Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.

Authors:  S H Kardaun; P Sekula; L Valeyrie-Allanore; Y Liss; C Y Chu; D Creamer; A Sidoroff; L Naldi; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

Review 7.  DRESS syndrome: a case report and literature review.

Authors:  Cláudia Sofia Cardoso; Ana Margarida Vieira; Ana Paula Oliveira
Journal:  BMJ Case Rep       Date:  2011-06-03

8.  Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.

Authors:  V Descamps; E Mahe; N Houhou; L Abramowitz; F Rozenberg; S Ranger-Rogez; B Crickx
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

Review 9.  DRESS syndrome: Part I. Clinical perspectives.

Authors:  Zain Husain; Bobby Y Reddy; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2013-05       Impact factor: 11.527

10.  Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection.

Authors:  Etsuro Nanishi; Takayuki Hoshina; Shouichi Ohga; Hisanori Nishio; Toshiro Hara
Journal:  J Microbiol Immunol Infect       Date:  2014-07-26       Impact factor: 4.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.